VIM
MRVI icon

VELA Investment Management’s Maravai LifeSciences MRVI Stock Holding History

VELA Investment Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-242,962
Closed -$586K – 186
2025
Q2 		$586K Buy
242,962
+86,628
+55% +$182K 0.16% 132
2025
Q1 		$345K Buy
156,334
+8,222
+6% +$32.5K 0.11% 141
2024
Q4 		$807K Buy
148,112
+52,246
+54% +$336K 0.22% 115
2024
Q3 		$797K Hold
95,866
– – 0.25% 114
2024
Q2 		$686K Buy
95,866
+21,549
+29% +$186K 0.21% 121
2024
Q1 		$644K Hold
74,317
– – 0.22% 124
2023
Q4 		$487K Buy
74,317
+31,824
+75% +$206K 0.19% 127
2023
Q3 		$425K Buy
42,493
+24,111
+131% +$265K 0.19% 116
2023
Q2 		$228K Buy
+18,382
New +$248K 0.11% 133

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

VELA Investment Management's MRVI Position: Q3 2025 in Review

VELA Investment Management sold out of Maravai LifeSciences (MRVI) in Q3 2025, closing a stake of 242,962 shares — an estimated $586K sold.

VELA Investment Management first reported a position in MRVI in Q2 2023 and held it in 9 quarters. The position peaked at $807K in Q4 2024. 160 funds tracked by Wall St. Rank hold MRVI as of Q3 2025.

  • VELA Investment Management reported no remaining Maravai LifeSciences position as of Q3 2025 after selling out during the quarter.
  • VELA Investment Management sold 242,962 Maravai LifeSciences shares in Q3 2025, an estimated $586K.
  • VELA Investment Management first reported a position in Maravai LifeSciences in Q2 2023 and held it in 9 quarters.
  • VELA Investment Management's Maravai LifeSciences position peaked at $807K in Q4 2024.
  • 160 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2025.

Based on VELA Investment Management's 13F filing for Q3 2025, filed 30 Oct 2025.